Glenmark Pharma gets UDFDA nod for first generic out of US facility

Glenmark Pharma gets UDFDA nod for first generic out of US facility

2018-06-19T09:04:12+00:00 On

Glenmark Pharmaceuticals received a boost for its plans to manufacture drugs within the US, with the FDA approving the first generic manufacturing application from the facility. The FDA approved the manufacturing of Atovaquone and Proguanil Hydrochloride Tablets at its Monroe, North Carolina facility via…